Larvol Delta - CERo-Therapeutics-Holdings-Inc-Announces-Initial-Clinical-Trial-Site-for-its-Phase-1-Clinical-Trial-of-CER1236-in-Acute-Myeloid-Leukemia

CER-1236 - CERo Therap

https://www.globenewswire.com/news-release/2025/04/09/3058386/0/en/CERo-Therapeutics-Holdings-Inc-Announces-Initial-Clinical-Trial-Site-for-its-Phase-1-Clinical-Trial-of-CER-1236-in-Acute-Myeloid-Leukemia.html

Apr 9, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next